As of 10:30 AM on the 10th, Myungmoon Pharmaceutical is trading at 6,450 KRW, up 0.47% from the previous day. This marks a 19.44% increase compared to July 16. Myungmoon Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.
Today, foreigners have a net purchase of 17,000 shares of Myungmoon Pharmaceutical, while institutions have a net sale of 4,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 974,817 shares, while foreigners and institutions have net sold 624,738 shares and 353,326 shares, respectively.
On August 7, Myungmoon Pharmaceutical became a market issue with the headline "Following the deworming effect, the battle for COVID-19 treatment."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
